|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"huang cj"
Showing items 1-10 of 297 (30 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-09-01 |
Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: A marker of aggressive tumor behavior
|
Wang, WC;Huang, CJ;Hsu, HP;Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;He, HL |
| 國家衛生研究院 |
2025-03 |
Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis
|
Su, YY;Lin, MY;Cheng, SM;Chang, WL;Hsu, CW;Yeh, CM;Yu, CC;Hou, YC;Huang, CJ;Liu, YS;Chao, YJ;Wang, DY;Shan, YS;Chen, LC |
| 國家衛生研究院 |
2025-02-21 |
Construction of hot tumor classification models in gastrointestinal cancers
|
Huang, CJ;Liu, GT;Yeh, YC;Chung, SY;Chang, YC;Chiang, NJ;Lu, ML;Huang, WN;Chen, MH;Wang, YC |
| 國家衛生研究院 |
2025-01-27 |
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
|
Chung, SY;Yeh, YC;Huang, CJ;Chiang, NJ;Hsu, DS;Chan, MH;Lu, ML;Hsu, TS;Hung, YP;Yeh, CN;Hsiao, M;Chang, YC;Wang, YC;Chen, MH |
| 國家衛生研究院 |
2024-12-08 |
Integrating a data curation artificial intelligence system to identify cancer registry data elements from unstructured electronic health records
|
Yang, YH;Dai, HJ;Tsai, JH;Chang, YC;Wang, TY;Ke, CR;Yu, SJ;Liu, YH;Huang, CJ;Lee, CJ;Lee, YH;Liang, JR;Fu, WM;Liao, SC;Kuo, SJ;Huang, CY;Lin, LJ;Wu, CC;Chang, GC;Chong, IW |
| 國家衛生研究院 |
2024-12 |
Integrating predictive coding and a user-centric interface for enhanced auditing and quality in cancer registry data
|
Dai, HJ;Chen, CC;Mir, TH;Wang, TY;Wang, CK;Chang, YC;Yu, SJ;Shen, YW;Huang, CJ;Tsai, CH;Wang, CY;Chen, HJ;Weng, PS;Lin, YX;Chen, SW;Tsai, MJ;Juang, SF;Wu, SY;Tsai, WT;Huang, MY;Huang, CJ;Yang, CJ;Liu, PZ;Huang, CW;Huang, CY;Wang, WYC;Chong, IW;Yang, YH |
| 國家衛生研究院 |
2024-09 |
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer
|
Su, YY;Bai, LY;Huang, CJ;Chiu, CF;Wang, HT;Du, JS;Wang, HC;Chuang, S;Shih, YH;Lin, HC;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2024-08-13 |
Evaluation of glucose-lowering medications in older people: A comprehensive systematic review and network meta-analysis of randomized controlled trials
|
Pan, SY;Su, EL;Huang, CJ;Chuang, SY;Chiang, CE;Chen, CH;Cheng, HM |
| 國家衛生研究院 |
2024-08-13 |
Dissecting the vascular-cognitive nexus: energetic vs. conventional hemodynamic parameters[Erratum:Hypertension Research. 2024 Jul 09;47:2262-2274.]
|
Cheng, HM;Wang, JJ;Chuang, SY;Lin, CH;Mitchell, GF;Huang, CJ;Wang, PN;Chung, CP;Chen, LK;Pan, WH;Peng, LN;Chen, CH |
| 國家衛生研究院 |
2024-08-12 |
A phase I/II study of nanoliposomal irinotecan and carboplatin in patients with advanced or metastatic, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma characterized by tissue and liquid next-generation sequencing
|
Chiang, NJ;Li, CF;Bai, LY;Huang, CJ;Yen, CC;Hsiao, CF;Wu, LC;Chen, MH |
Showing items 1-10 of 297 (30 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
